Genomics Reporting Implementation Guide, published by HL7 International / Clinical Genomics. This guide is not an authorized publication; it is the continuous build for version 3.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/genomics-reporting/ and changes regularly. See the Directory of published versions
Generated Narrative: Observation TMB-therapuDrug
status: Final
category: Laboratory, Genetics
code: Therapeutic Implication
effective: 2023-02-01
performer: Practitioner Test Dolin
derivedFrom: Observation Mutations/Megabase [# Ratio] in Tumor
component
code: Therapeutic Implication
value: cancer sensitive to pembrolizumab
component
code: Associated phenotype
value: Non-small cell lung cancer
component
code: Medication assessed
value: Pembrolizumab
component
code: Conclusion Text
value: Non-small cell lung cancer with high TMB is sensitive to pembrolizumab